TRANSGENOMIC INC

Inactive Instrument

Insiders Transgenomic Inc Nasdaq

Equities

US89365K3059

End-of-day quote Nasdaq Other stock markets
- ^USD	-

05-14	Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-19	Precipio, Inc. announced that it expects to receive $0.5 million in funding	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Precipio, Inc. Announces Board Changes	01-02	CI
Precipio, Inc. Appoints Sharon Robins as its Senior Director of Laboratory & Hospital Sales for the Product’s Division	22-08-24	CI
Precipio, Inc. Welcomes Toni-Ann Mills as its Senior Director for Learning & Development	22-08-10	CI
Precipio, Inc. Appoints Keith Meadors as Senior Vice President of its Products Division	22-06-13	CI
Precipio Chief Financial Officer Resigns; Matt Gage Appointed as Interim CFO	22-03-21	MT
Insider Trends: Precipio Insider Extends 90-Day Selling Trend	21-08-03	MT
Insider Trends: 90-Day Insider Selling Trend Prolonged at Precipio	21-08-03	MT
Precipio, Inc. Announces Board and Committee Changes	21-03-03	CI
Precipio, Inc. Announces Board Changes	19-12-04	CI
Precipio, Inc. Appoints Ori Karev as Chief Strategy Officer	19-04-18	CI
Precipio, Inc Announces Board Changes	18-08-09	CI
Precipio, Inc. Appoints Douglas Sites as Vice President of Sales	18-01-16	CI
Precipio, Inc. Announces Board Changes	17-11-14	CI
Precipio, Inc. Elects Jeffrey Cossman and Douglas Fisher to its Board of Directors	17-10-02	CI
Transgenomic, Inc. and Precipio Diagnostics, LLC Appoints Ilan Danieli as Chief Executive Officer of the Combined Company	16-10-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer